The study is investigating the safety and tolerability of LX9851, how it moves through the body and its physiological and ...
Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and ...
The Obesity Charter for Cambridgeshire and Peterborough set out a vision in which "healthy weight is the norm" within 20 ...
Children living with obesity but showing no signs of metabolic complications still have a significantly increased risk of ...
Children living with obesity but showing no signs of metabolic complications still have a significantly increased risk of ...
The U.S. Food and Drug Administration expanded the use of Rhythm Pharmaceuticals’ therapy for a rare form of obesity caused ...
Obesity is a chronic disease that can significantly affect an individual’s overall health. In this Care Cues, experts discuss ...
Rhythm Pharmaceuticals is switching up the tempo for its melanocortin-4 receptor (MC4R) agonist Imcivree. | The new FDA nod ...
Type 2 diabetes (T2D) and obesity are metabolic conditions with many causes, including overlapping and distinct genetic ...
Evaluation of a rural pediatric obesity program highlights strengths in structured care delivery while identifying gaps in ...
A new Pediatrics study is putting a spotlight on something most parents don’t think about when it comes to kids’ health: ...
Childhood obesity rates are declining slightly in Oklahoma, offering cautious optimism for families across the state. Pediatrician Dr. Scott Cyrus joined News On 6 to explain what the latest data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results